NCT02916511View on ClinicalTrials.gov

Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2023

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Paclitaxel

paclitaxel 50mg/m2/d, ivgtt over 3 hours, d1, qw\*5

DRUG

Carboplatin

carboplatin AUC=2, ivgtt, d1, qw\*5

RADIATION

Radiotherapy

1.8Gy/d, d1-5/week, 25Fx

Trial Locations (1)

200032

Fudan Universtiy Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT02916511 - Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter